i n f l a r x

Loading

About Inflarx
R & D
Investors
Careers
The InflaRx Commitment

About Inflarx
R & D
Investors
Careers
The InflaRx Commitment

Impressum Privacy policy

Contact us

+49 3641 508 180

info@inflarx.de

Address

Winzerlaer Str. 2, 07745 Jena

Press Release

Home Investors Press Releases Press Release

InflaRx Provides Update on Vilobelimab (IFX-1) Development

Jan 11, 2021

Time to read 4 Minutes

Download PDF

Back

Contact Jena

InflaRx N.V. / InflaRx GmbH
Winzerlaer Str. 2
07745 Jena

+49 3641 508 180

info@inflarx.de
InflaRx on Linkedin

Contact Munich

InflaRx N.V. / InflaRx GmbH
Fraunhoferstraße 22
82152 Martinsried

+49 89 414 189 78 00

info@inflarx.de

Contact Ann Arbor

InflaRx Pharmaceuticals Inc.
600 S. Wagner Rd.
Ann Arbor, MI 48103

info@inflarx.de

© 2023 InflaRx All Rights Reserved.

Privacy Policy The InflaRx Commitment

You are now leaving inflarx.de.

Click "Cancel" to return to inflarx.de or "Visit Site" to proceed.

Cancel Visit Site

externalLinkTitle